The use of three FDA-approved AI systems (LumineticsCore (formerly IDx-DR), EyeArt, and AEYE Diagnostic Screening) in retinopathy screening in primary healthcare. Of particular interest were the technical performance of the devices, the efficiency of the screening process, and the economic impacts.
Looks like things are working quite well!
https://www.sciencedirect.com/science/article/pii/S2666914525002337